Chanson Brumme

Получаване на мой собствен потребителски профил

Позовавания

	Всички	От 2019
Позовавания	10026	3481
h-индекс	46	32
i10-индекс	101	75

780

390

195

585

200620072008200920102011201220132014201520162017201820192020202120222023202453 124 138 320 479 612 749 760 774 750 577 602 537 582 553 626 683 633 398

Публичен достъп

Преглед на всички

113 статии

6 статии

налични

неналични

Въз основа на изисквания при финансирането

Съавтори

Zabrina BrummeAssociate Professor, Faculty of Health Sciences, Simon Fraser UniversityПотвърден имейл адрес: sfu.ca
Mark A. BrockmanSimon Fraser University and BC Centre for Excellence in HIV/AIDSПотвърден имейл адрес: sfu.ca
Dr. Julio Montaner, OC, OBC, MD, FR...Director of the BC-CfE; Director of IDC and Physician Program Director for HIV/AIDS PHCПотвърден имейл адрес: bccfe.ca
Jonathan CarlsonManaging Director, Health Futures, Microsoft ResearchПотвърден имейл адрес: microsoft.com
David HeckermanMicrosoft ResearchПотвърден имейл адрес: microsoft.com
Robert HoggFaculty of Health Sciences, Simon Fraser UniversityПотвърден имейл адрес: sfu.ca
Simon MallalDirector, Institute for Immunology and Infectious Diseases, Murdoch University, Western AustraliaПотвърден имейл адрес: iiid.com.au
Todd M. AllenProfessor of Medicine, Ragon Institute of MGH, MIT and HarvardПотвърден имейл адрес: partners.org
Florencia PereyraAssistant Professor of Medicine, Harvard Medical SchoolПотвърден имейл адрес: partners.org
Guinevere Q. LeeWeill Cornell MedicineПотвърден имейл адрес: med.cornell.edu
Jeffrey B JoyCentre for Excellence in HIV/AIDS, Department of Medicine, University of British ColumbiaПотвърден имейл адрес: cfenet.ubc.ca
Art FY PoonWestern UniversityПотвърден имейл адрес: uwo.ca
David BangsbergProvost and Dean College of Health Sciences, VinUniversityПотвърден имейл адрес: vinuni.edu.vn
Luke C Swenson, MD, PhDUniversity of TorontoПотвърден имейл адрес: mail.utoronto.ca
Bethany M HenrickVP, Microbiome, Brightseed BioПотвърден имейл адрес: unl.edu
Susan LittleUniversity of California San DiegoПотвърден имейл адрес: health.ucsd.edu
Viviane Dias LimaBC Centre for Excellence in HIV/AIDS & University of British ColumbiaПотвърден имейл адрес: bccfe.ca
Peter HuntUniversity of California San FranciscoПотвърден имейл адрес: php.ucsf.edu
Alissa RothchildUniversity of Massachusetts AmherstПотвърден имейл адрес: umass.edu
David JHF KnappProfesseur sous octroi adjoint, IRIC | Université de MontréalПотвърден имейл адрес: umontreal.ca

Следене

Chanson Brumme

Assistant Professor, Faculty of Medicine, University of British Columbia

Потвърден имейл адрес: bccfe.ca - Начална страница

HIV Hepatitis C Molecular Diagnostics


Заглавие Сортиране по цитати Сортиране по година Сортиране по заглавие	Позовавания Позовавания	Година
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation International HIV Controllers Study Science 330 (6010), 1551-1557, 2010	1131	2010
Predictors of HIV drug-resistance mutations in a large antiretroviral-naive cohort initiating triple antiretroviral therapy PR Harrigan, RS Hogg, WWY Dong, B Yip, B Wynhoven, J Woodward, ... The Journal of infectious diseases 191 (3), 339-347, 2005	562	2005
Adaptation of HIV-1 to human leukocyte antigen class I Y Kawashima, K Pfafferott, J Frater, P Matthews, R Payne, M Addo, ... Nature 458 (7238), 641-645, 2009	561	2009
Influence of HLA-C expression level on HIV control R Apps, Y Qi, JM Carlson, H Chen, X Gao, R Thomas, Y Yuki, ... Science 340 (6128), 87-91, 2013	412	2013
Whole genome deep sequencing of HIV-1 reveals the impact of early minor variants upon immune recognition during acute infection MR Henn, CL Boutwell, P Charlebois, NJ Lennon, KA Power, ... PLoS pathogens 8 (3), e1002529, 2012	397	2012
HLA-B57/B* 5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T … T Miura, MA Brockman, A Schneidewind, M Lobritz, F Pereyra, A Rathod, ... Journal of virology 83 (6), 2743-2755, 2009	358	2009
Molecular and clinical epidemiology of CXCR4-using HIV-1 in a large population of antiretroviral-naive individuals ZL Brumme, J Goodrich, HB Mayer, CJ Brumme, BM Henrick, ... The Journal of infectious diseases 192 (3), 466-474, 2005	353	2005
Antigen Load and Viral Sequence Diversification Determine the Functional Profile of HIV-1–Specific CD8⁺ T Cells H Streeck, ZL Brumme, M Anastario, KW Cohen, JS Jolin, A Meier, ... PLoS medicine 5 (5), e100, 2008	317	2008
Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells H Streeck, JS Jolin, Y Qi, B Yassine-Diab, RC Johnson, DS Kwon, ... Journal of virology 83 (15), 7641-7648, 2009	275	2009
Marked epitope-and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early … ZL Brumme, CJ Brumme, J Carlson, H Streeck, M John, Q Eichbaum, ... Journal of virology 82 (18), 9216-9227, 2008	222	2008
HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins ZL Brumme, M John, JM Carlson, CJ Brumme, D Chan, MA Brockman, ... PloS one 4 (8), e6687, 2009	210	2009
Automating HIV drug resistance genotyping with RECall, a freely accessible sequence analysis tool CK Woods, CJ Brumme, TF Liu, CKS Chui, AL Chu, B Wynhoven, TA Hall, ... Journal of clinical microbiology 50 (6), 1936-1942, 2012	208	2012
Evidence of differential HLA class I-mediated viral evolution in functional and accessory/regulatory genes of HIV-1 ZL Brumme, CJ Brumme, D Heckerman, BT Korber, M Daniels, J Carlson, ... PLoS pathogens 3 (7), e94, 2007	206	2007
Definition of the viral targets of protective HIV-1-specific T cell responses B Mothe, A Llano, J Ibarrondo, M Daniels, C Miranda, J Zamarreño, ... Journal of translational medicine 9, 1-20, 2011	192	2011
Phylogenetic dependency networks: inferring patterns of CTL escape and codon covariation in HIV-1 Gag JM Carlson, ZL Brumme, CM Rousseau, CJ Brumme, P Matthews, ... PLoS computational biology 4 (11), e1000225, 2008	170	2008
HLA-Associated Alterations in Replication Capacity of Chimeric NL4-3 Viruses Carrying gag-protease from Elite Controllers of Human Immunodeficiency Virus Type 1 T Miura, MA Brockman, ZL Brumme, CJ Brumme, F Pereyra, A Trocha, ... Journal of virology 83 (1), 140-149, 2009	157	2009
Genetic characterization of human immunodeficiency virus type 1 in elite controllers: lack of gross genetic defects or common amino acid changes T Miura, MA Brockman, CJ Brumme, ZL Brumme, JM Carlson, F Pereyra, ... Journal of virology 82 (17), 8422-8430, 2008	156	2008
Early selection in Gag by protective HLA alleles contributes to reduced HIV-1 replication capacity that may be largely compensated for in chronic infection MA Brockman, ZL Brumme, CJ Brumme, T Miura, J Sela, PC Rosato, ... Journal of virology 84 (22), 11937-11949, 2010	152	2010
Impaired replication capacity of acute/early viruses in persons who become HIV controllers T Miura, ZL Brumme, MA Brockman, P Rosato, J Sela, CJ Brumme, ... Journal of virology 84 (15), 7581-7591, 2010	151	2010
A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control I Bartha, JM Carlson, CJ Brumme, PJ McLaren, ZL Brumme, M John, ... elife 2, e01123, 2013	147	2013

Системата не може да изпълни операцията сега. Опитайте отново по-късно.

Статии 1–20

Позовавания годишно

Дублирани описания

Обединени библиографски описания

Добавяне на съавториСъавтори

Следене

Позовавания

Съавтори